| Fenfluramine Hydrochloride | Zogenix | ||
| 2.2 mg/mL ; Solution |
Less Than $1000 mn
|
||
|
Less Than 5
|
Less Than 5
|
||
|
Less Than 5
|
None | ||
|
Less Than 5
|
None | ||
| FINTEPLA is indicated for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older | |||
|
Yes
| |||
| Fintepla | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ****** | *** ********* | *** ********* | ********* ** ***** ** ****** | *** ********* | *** ********* | *** ********* | *** ********* | **** ** *** **, **** | ********* ** ***** ** ****** | ********* ** ***** ** ****** | *** ********* | **** ** *** **, **** (***** ******) | ********* ** ***** ** ****** |
| ***** | **** ** *** *, **** | **** ** *** *, **** | ********* ** ***** ** ***** | **** ** *** *, **** | *** ********* | **** ** *** *, **** | **** ** *** *, **** | *** ********* | ********* ** ***** ** ***** | ********* ** ***** ** ***** | *** ********* | ********* ** ***** ** ***** (***** ******) | *** ********* |
| ************ ************ *** ******* ** ********* *** **** | ******* ****** *** ******* ** ************ ** ********** | ****** *** *** ********* ** ****** ******** | ****** *** *** ********* ** ****** ******** | *********** *** ********** ********* ** *-**** ******** *** ******* ** ***** **** | ************ ************ *** ******* ** ********* *** **** | ******* ****** *** ******* ** ************ ** ********** | *********** *** ********** ********* ** *-**** ******** *** ******* ** ***** **** | *********** *** ********** ********* ** *-**** ******** *** ******* ** ***** **** | ****** *** *** ********* ** ****** ******** | ****** *** *** ********* ** ****** ******** | ****** *** *** ********* ** ****** ******** | ****** *** *** ********* ** ****** ******** |
| Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
|---|---|---|---|---|---|
| ****** | *** / ** | *** **, **** | ******* / ********* ** ***** ** ****** | ******** | ******* *** **** *** *** **** |
| ***** | ** / ** | *** **, **** | ******* / ********* ** ***** ** ***** | **** | ******* *** **** *** *** **** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|